Tuesday, 31 March 2020

China News

  • China Cord Blood revenue rises 30%

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

    Singapore: China Cord Blood (CCBC) revealed its preliminary unaudited financial results for the second quarter and first half of fiscal year 2013, ending September 30, 2012. Revenues for t...Read more

  • Fosun gets listed on Hong Kong stock exchange

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Oct, 2012

    Singapore: Shanghai Fosun Pharmaceutical is going to list its shares on the main board of Stock Exchange of Hong Kong Limited (SEHK). The Hong Kong public offering opened at 9:00 am on Oct...Read more

  • PSM expands in China to curb counterfeit drugs

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Partnership for Safe Medicines (PSM) has set up its offices in China.  PSM China launch event was held in Beijing and was attended by stakeholders from the government, advocac...Read more

  • Chinese medical device market has many pitfalls

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

    Singapore: A new report by Millennium Research Group about the Chinese medical device market highlighted that success in the market depends on balancing risks such as the complex tendering ...Read more

  • Pharmaron, AstraZeneca sign drug discovery deal

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Singapore: Pharmaron entered into a drug discovery partnership with AstraZeneca to support their global Innovative Medicines Units. Under this multi-year agreement, Pharmaron will provide ...Read more

  • HKAPI: We need more manpower to implement new initiatives

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Founded in 1968, the Hong Kong Association of the Pharmaceutical Industry (HKAPI) has 71 members, which includes the 20 top global pharmaceutical companies. HKAPI's member companies supply ...Read more

  • Chinese medicine firm Tianyin gets GMP certificate

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

    Singapore: China-based Tianyin Pharmaceutical (TPI) received GMP certification for its pre-extraction plant and formulate facilities. Tianyin Pharmaceutical is a pharmaceutical company th...Read more

  • Mindray expects 20% growth in FY2012

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

    Singapore: Mindray Medical, a China-based manufacturer and marketer of medical devices, is expecting an year-over-year growth of 20 percent, touching $1,056 million by the fiscal year endin...Read more

  • Lumenis to distribute Visionix products in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Lumenis, the world's largest medical laser company for ophthalmic, aesthetic, and surgical applications, and Visionix, a worldwide leader in wavefront technology for visual acuit...Read more

  • Japan gives patent for Medgenics IFNa pump

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Dec, 2012

    Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protecting the use of Medgenics' Infradure Biopump technology for the deli...Read more

  • Franc Kaiser: Chinese M&A to heat up substantially in 2013

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    The M&A climate had started to heat up in 2012, and it is likely to get hotter in 2013. The majority of China's 2012 deal activities was related to drug manufacturing assets and drug co...Read more

  • Pall inaugurates Centre of Excellence in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2013

    Singapore: Pall Corporation, a global leader in filtration, separation and purification, has inaugurated Pall Life Sciences Centre of Excellence (CoE) at its Zhangjiang site in Shanghai, Ch...Read more

  • Allium wins $16.36 mn stent distribution deal in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

    Singapore: Israel-based Allium Medical signed a strategic agreement with Beijing King Health Investment to exclusively distribute its urinary tract stents for eight years in China. King He...Read more

  • Challenge No 9: Price cuts by govt

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Continuous drug price cuts will further squeeze margins for both multinational and domestic pharma. "The National Reform and Development Commission (NRDC), China's pricing regulatory body, ...Read more

  • China genomics institute installs Roche system

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

    Singapore: Beijing Genomics Institute (BGI), which is one of the world's largest genomics organizations, successfully installed Roche GS FLX+ System at its facility in Shenzhen, China, with...Read more

  • Policy reforms boost biotech talent pool

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

    Reforms in government policies and initiatives have helped in setting focus for bioscience companies, which has resulted in an enhanced manpower pool in Asia. Singapore has emerged as a hi...Read more

  • Exlites eyes more medtech deals from China, Taiwan, Japan

    China |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: Exlites Holdings from the US has entered into an agreement with a company that will source new cutting edge medical products from China, Taiwan and Japan. Exlites has gone into a...Read more

  • Nestle enters Chinese medicines market

    China |  News | By BioSpectrum Bureau  | 0 Comment | 04 Dec, 2012

    Singapore: Nestlé Health Science, a fully owned subsidiary of Nestlé, and the pharmaceutical and healthcare group Chi-Med have agreed to form a 50:50 joint venture called Nutrition S...Read more